SITAVIG® 50 mg, muco‐adhesive buccal tablets.
SITAVIG® is a single dose tablet indicated for the treatment of recurrent herpes labialis in immunocompetent adults with frequent herpes episodes.
Summary of product characteristics and patient leaflet will be available here:
Any report of an adverse reaction related to a Vectans Pharma drug should be made immediately by e-mail to [email protected]
For more information please ask your doctor.